Clin2
NCT04119102Possibly a fitRecruiting

Duobrii added to biologic treatment for plaque psoriasis

Psoriasis

Part of Skin clinical trials.

This trial tests whether adding Duobrii (a prescription psoriasis lotion) on top of your current biologic treatment helps improve plaque psoriasis. It includes adults whose psoriasis is in a moderate range and who have already been on a biologic for at least 24 weeks.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
25 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You have chronic plaque-type psoriasis
  • Your psoriasis affects about 2% to 10% of your body surface
  • You have been on a biologic psoriasis medicine for at least 24 weeks
  • You can and agree to sign informed consent before any study procedures
  • You have not used Duobrii before

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT03392337Recruiting
Narrowband UVB light therapy for moderate to severe plaque psoriasis

This study tests whether narrowband ultraviolet B (UVB) light given three times a week for 12 weeks improves moderate-to-severe plaque psoriasis. It is an “open-label” pilot, meaning everyone gets the UVB treatment and researchers track how your skin responds.

East Windsor, New Jersey
NCT07187817Recruiting
Sequential biologic treatments for psoriasis

This trial looks at how different biologic treatments work when used one after another for people with plaque psoriasis. It may help find the best order of treatments to keep your skin clear.

Bath, Somerset
NCT07204639Recruiting· Phase 2
Testing CBP-0276 for moderate to severe psoriasis

This trial tests a new medication, CBP-0276, to see if it improves psoriasis symptoms and quality of life. It is for people with moderate to severe plaque psoriasis who might need stronger treatment.

Mexico City
NCT07265284Recruiting· Phase 3
IBI112 for teens with moderate to severe plaque psoriasis

This study tests a new medicine called IBI112 for teens aged 12–18 with moderate to severe plaque psoriasis. It aims to see if the medicine is safe and can help clear skin better than placebo.

Beijing, Beijing Municipality
NCT06477237Recruiting· Phase 3
Testing a new psoriasis shot for moderate to severe plaque

This trial tests a new medication called HB0017 for moderate to severe plaque psoriasis. It aims to see if it is safe and effective in reducing skin symptoms and improving quality of life.

Jiangmen, Guangdong
NCT06399432Recruiting
Mediterranean diet for psoriasis patients on biologic therapy

This study tests whether adding a Mediterranean diet to your psoriasis treatment can improve your skin. You will be asked to follow a heart-healthy diet for several months while taking a new biologic medicine.

Cleveland, Ohio

Hear when a new Psoriasis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.